This systematic review explores the findings of these studies, focusing on the implications of cystatin C as a predictor of disease severity and mortality [21]. Our research corroborates the findings of Zinellu et al., reinforcing the importance of cystatin C as a biomarker in COVID-19. Here, CST3 is linked to COVID-19.